Related Experiment Videos
Red cell spectrin phosphorylation and cytoskeletal anchorage.
Journal of Cardiovascular Pharmacology
|January 1, 1986
Summary
Cyclic AMP (cAMP) triggers spectrin phosphorylation in human red blood cells, altering its binding properties and resistance to extraction. This phosphorylation is age-dependent and may be modulated by calcium-calmodulin interactions.
Area of Science:
- Cellular Biology
- Biochemistry
- Hematology
Background:
- Spectrin is a key cytoskeletal protein in human red blood cells, essential for maintaining cell shape and stability.
- Phosphorylation is a critical post-translational modification regulating protein function.
Purpose of the Study:
- To investigate the effects of cyclic AMP (cAMP) on spectrin phosphorylation in intact human red blood cells.
- To characterize the functional consequences of cAMP-dependent spectrin phosphorylation on its binding properties.
Main Methods:
- Incubation of intact human red blood cells with cAMP.
- Extraction of spectrin under low ionic strength conditions.
- Analysis of spectrin phosphorylation in vitro and in vivo using radiolabeling.
- Investigation of calcium-calmodulin effects on purified spectrin dimer.
Main Results:
- cAMP-dependent phosphorylation of spectrin was observed in intact red blood cells.
- Phosphorylated spectrin exhibited altered binding properties, showing resistance to low ionic strength extraction and remaining associated with inside-out vesicles.
- In vitro, cAMP-dependent phosphorylation labeled both spectrin subunits.
- In vivo, spectrin band 1 phosphorylation increased with red blood cell age.
- Calcium-calmodulin selectively inhibited cAMP-dependent labeling of spectrin band 1 in purified spectrin.
Conclusions:
- cAMP-dependent phosphorylation modifies spectrin's interaction with the red blood cell membrane.
- The age-dependent phosphorylation of spectrin suggests a role in red blood cell aging.
- Calcium-calmodulin may play a regulatory role in spectrin phosphorylation, potentially influencing young red blood cell spectrin modification.